Science Lecanemab, a new treatment for Alzheimer's, shows infrequent side effects in real-world scenarios. , and Administrator 2025 May 23
Dementia Lecanemab's real-world effects reveal infrequent occurrence of adverse reactions in Alzheimer's patients. , and Administrator 2025 May 20
